CRISPR-Cas13a diagnostics for circulating microbial transcripts in pancreatic cancer.

Muhammad Shahid Mehmood1, Inbsaat Iqbal2, Fatima Hajj3

  • 1Institute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.

Summary

This study proposes a novel, low-cost diagnostic tool for pancreatic cancer using CRISPR-Cas13a technology and microbial RNA biomarkers. This rapid liquid biopsy offers high accuracy for early pancreatic ductal adenocarcinoma detection.